![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/JBCHEPHARM.png)
Share the post "JBCHEMICALS & PHARMACEUTICAL’s Q3 2024-25 Latest News: Profit Grows by 21.65% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 14.09 % in the past year, decrease in net sales/revenue by -3.71 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 8.84 %. Marginal decrease of -19.6% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for J.B.CHEMICALS & PHARMACEUTICAL. Notable increase of 21.65 % in net profit Year to Year, J.B.CHEMICALS & PHARMACEUTICAL’s profitability dropped by -6.92 % Quarter to Quarter. 🔹 EPS over the Year and quarter: EPS increased by 21.35 % Year to Year. EPS decreased by -6.94 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 844.51 Cr | Rs. 1000.62 Cr | Rs. 963.49 Cr | -3.71 % | + 14.09 % |
| Expenses | Rs. 621.39 Cr | Rs. 730.1 Cr | Rs. 708.98 Cr | -2.89 % | + 14.1 % |
| Operating Profit | Rs. 223.12 Cr | Rs. 270.52 Cr | Rs. 254.51 Cr | -5.92 % | + 14.07 % |
| OPM % | 26.42 % | 27.04 % | 26.42 % | -0.62 % | + 0 % |
| Other Income | Rs. 7.35 Cr | Rs. 9.95 Cr | Rs. 8 Cr | -19.6 % | + 8.84 % |
| Interest | Rs. 12.49 Cr | Rs. 2.06 Cr | Rs. 2.58 Cr | + 25.24 % | -79.34 % |
| Depreciation | Rs. 34.03 Cr | Rs. 41.88 Cr | Rs. 41.94 Cr | + 0.14 % | + 23.24 % |
| Profit before tax | Rs. 183.95 Cr | Rs. 236.53 Cr | Rs. 217.99 Cr | -7.84 % | + 18.51 % |
| Tax % | 27.39 % | 26.2 % | 25.46 % | -0.74 % | -1.93 % |
| Net Profit | Rs. 133.57 Cr | Rs. 174.57 Cr | Rs. 162.49 Cr | -6.92 % | + 21.65 % |
| EPS in Rs | Rs. 8.46 | Rs. 11 | Rs. 10.24 | -6.91 % | + 21.04 % |
Today, we’re looking at J.B.CHEMICALS & PHARMACEUTICAL’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 14.09 %. However, it did see a marginal slip of -3.71 % from the previous quarter. Expenses decreased slightly by -2.89 % quarter-on-quarter, aligning with the annual rise of 14.1 %. Operating profit, while up 14.07 % compared to last year, faced a quarter-on-quarter dip of -5.92 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0 %, but a shrinkage of -0.62 % sequentially. Other income fell by -19.6 % compared to the last quarter, despite an annual growth of 8.84 %. Interest expenses surged remarkably by 25.24 % from the previous quarter, yet the year-over-year decrease remains at a moderate -79.34 %. Depreciation costs climbed by 0.14 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 23.24 %. Profit before tax grew annually by 18.51 % but saw a reduction from the preceding quarter by -7.84 %.
Tax expenses as a percentage of profits decreased slightly by -1.93 % compared to last year, with a more notable quarter-on-quarter decrease of -0.74 %. Net profit rose by 21.65 % year-on-year but witnessed a -6.92 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 21.04 % but a quarterly fall of -6.91 %. In summary, J.B.CHEMICALS & PHARMACEUTICAL’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 844.51 Cr | Rs. 1000.62 Cr | Rs. 963.49 Cr | -3.71 % | + 14.09 % |
| Expenses | Rs. 621.39 Cr | Rs. 730.1 Cr | Rs. 708.98 Cr | -2.89 % | + 14.1 % |
| Operating Profit | Rs. 223.12 Cr | Rs. 270.52 Cr | Rs. 254.51 Cr | -5.92 % | + 14.07 % |
| Net Profit | Rs. 133.57 Cr | Rs. 174.57 Cr | Rs. 162.49 Cr | -6.92 % | + 21.65 % |
| EPS in Rs | Rs. 8.46 | Rs. 11 | Rs. 10.24 | -6.91 % | + 21.04 % |
In reviewing J.B.CHEMICALS & PHARMACEUTICAL’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 14.09 % year-on-year growth, although there was a slight dip of -3.71 % from the previous quarter. Expenses rose by 14.1 % compared to the previous year, with a decrease of -2.89 % quarter-on-quarter. Operating Profit surged by 14.07 % annually, and saw a -5.92 % decrease from the last quarter.
Net Profit showed yearly increase of 21.65 %, and experienced a -6.92 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 21.04 % annually, however dipped by -6.91 % compared to the last quarter. In essence, while J.B.CHEMICALS & PHARMACEUTICAL exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/WABAG.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/STL.png)
